Centene Corporation (NYSE: CNC ) offers a variety of healthcare insurance products, including Medicare, Medicaid, and more. A few days ago, shares of this company plunged after the company withdrew guidance for 2025, with much of this being driven byLong-time stock market investor focused on strategic buying opportunities with dividend and value stocks. This investment strategy has resulted in a near 5 star rating on Tipranks.com and over 9,000 followers on Seeking Alpha. Follow me on Twitter for my latest ...

Core Insights - The article discusses Intel Corporation's stock performance and management credibility issues under former CEO Pat Gelsinger, suggesting a buying opportunity as the stock price had dropped significantly from around $30 [1]. Group 1: Company Performance - Intel's stock price experienced a decline, prompting the suggestion to buy shares due to the perceived undervaluation [1]. Group 2: Management Credibility - There were concerns regarding management credibility during the tenure of former CEO Pat Gelsinger, which may have impacted investor confidence [1].